Literature DB >> 25811644

Risk factors for TB and HIV coinfection in Scotland, 2001 to 2010.

E McDonald1, A Smith-Palmer, L A Wallace, O Blatchford.   

Abstract

The number of patients with tuberculosis (TB) increased steadily in Scotland between 2005 and 2010. Human immunodeficiency virus (HIV) infection has been a contributory factor to increases in TB in a number of comparable industrialised countries. This study investigated the extent of, and risk factors for, TB and HIV coinfection in Scotland from 2001 to 2010. Patients with TB in the national TB database were linked to those in the national HIV database using probabilistic data linkage. Patient records were anonymised to maintain confidentiality. From 2001 to 2010, 106/4, 097 (2.6%, 95% CI: 2.1 to 3.1) TB patients matched with HIV patients, equating to a 10-year incidence of 2.1 cases per million population. Patients with both TB and HIV were more often born outside the United Kingdom,were of black African ethnicity, had refugee status and had extra-thoracic lymph node involvement or cryptic/disseminated TB disease. Individuals with TB and HIV coinfection were younger and symptomatic for a shorter time before their diagnosis of TB, compared with TB patients without HIV. TB and HIV coinfection was relatively uncommon in Scotland in the study period. Clinicians should recognise the potential for HIV infection among TB patients and the importance of offering an HIV test to all TB patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811644     DOI: 10.2807/1560-7917.es2015.20.11.21067

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  2 in total

1.  Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean.

Authors:  Ralfh Moreno; Giovanni Ravasi; Pedro Avedillo; Rafael Lopez
Journal:  Rev Panam Salud Publica       Date:  2020-05-22

2.  Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.

Authors:  Maíra Rossetto; Évelin Maria Brand; Renata Mendonça Rodrigues; Laura Serrant; Luciana Barcellos Teixeira
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.